Form 8-K - Current report:
SEC Accession No. 0000950170-24-021648
Filing Date
2024-02-28
Accepted
2024-02-28 07:10:15
Documents
14
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rptx-20240228.htm   iXBRL 8-K 39875
2 EX-99.1 rptx-ex99_1.htm EX-99.1 194919
3 GRAPHIC img233743075_0.jpg GRAPHIC 13149
  Complete submission text file 0000950170-24-021648.txt   381090

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20240228.xsd EX-101.SCH 24812
15 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20240228_htm.xml XML 4709
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 24690151
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)